Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.16 -0.08 (-6.45%)
As of: Oct 2, 2026 · 12:32 PM EDT

Tvardi Therapeutics (TVRD) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Tvardi Therapeutics (TVRD) posted Depreciation & Amortization (CF) of $23,000 for Q2 2026, unchanged from $23,000 a year earlier and down 4.2% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Tvardi Therapeutics was $95,000, unchanged year-over-year; for FY2025, it came in at $95,000, unchanged from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -14.6% (FY2020 to FY2025).
  • In prior years, Tvardi Therapeutics' Depreciation & Amortization (CF) was $95,000 in FY2024 (-63.3%), $259,000 in FY2023 (+4.4%), $248,000 in FY2022 (unchanged) and $248,000 in FY2021 (+18.7%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $5,000 in Q2 2024 to a high of $82,000 in Q4 2023 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with growth averaging 23.4%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2025, with growth of 360.0%; the weakest was Q2 2024, with a decline of 91.7%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $24,000 (Q1 2026), $24,000 (Q4 2025) and $24,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Tvardi Therapeutics 11.73 Mn 11.73 Mn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23,000.00
Mar 31, 2026 24,000.00
Dec 31, 2025 24,000.00
Sep 30, 2025 24,000.00
Jun 30, 2025 23,000.00
Mar 31, 2025 24,000.00
Dec 31, 2024 24,000.00
Sep 30, 2024 24,000.00
Jun 30, 2024 5,000.00
Mar 31, 2024 42,000.00
Dec 31, 2023 82,000.00
Sep 30, 2023 59,000.00
Jun 30, 2023 60,000.00
Mar 31, 2023 58,000.00
Dec 31, 2022 61,000.00
Sep 30, 2022 61,000.00
Jun 30, 2022 63,000.00
Mar 31, 2022 63,000.00
Dec 31, 2021 62,000.00
Sep 30, 2021 62,000.00
API Access

Tvardi Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TVRD&period=max&api_key=YOUR_API_KEY